Oxaliplatin "should now be considered standard treatment for stage III colon cancer," said presenting author Hans-Joachim Schmoll, MD, from the University Clinic Halle (Saale) in Germany. In this phase 3 randomized trial, 1806 patients with stage III …
Long-Term Survival Benefits in Colon Cancer With Oxaliplatin
